Isoprivir

Inosine Pranobex, the active ingredient in Isoprivir, is an immunomodulator presented as an oral tablet for oral use. It is used to support the immune response in viral infections such as herpes simplex, human papillomavirus, influenza and other respiratory tract infections.

GNH USA supplies Isoprivir as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isoprivir is an oral antiviral that modulates the immune system to combat several viral infections. - Herpes simplex infections: reduces lesion duration and severity. - Human papillomavirus infections: assists in viral clearance and lesion regression. - Influenza: shortens illness course and alleviates symptoms. - Respiratory tract infections: supports recovery by enhancing host defenses.

Adverse reactions may occur with any immunomodulatory therapy.

Common Side Effects: - Mild gastrointestinal upset: nausea or abdominal discomfort. - Headache: transient and usually resolves without intervention. - Dizziness: occasional light‑headedness reported. - Skin rash: mild erythema or pruritus.

Serious or Rare Side Effects: - Severe allergic reaction: anaphylaxis or angioedema. - Hematologic changes: leukopenia or thrombocytopenia. - Hepatic dysfunction: elevated liver enzymes. - Autoimmune manifestations: rare exacerbation of autoimmune disease.

Before initiating therapy, consider the following safety measures. - Pregnancy: safety not established; avoid use unless clearly needed. - Breastfeeding: unknown excretion; weigh benefits against potential risks. - Immunocompromised patients: monitor closely for infection progression. - Renal or hepatic impairment: adjust monitoring as clinically indicated. - Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture.

Inosine Pranobex may interact with other medications affecting immune function or metabolism.

Major Interactions (Avoid): - Immunosuppressants: may reduce antiviral efficacy. - Live vaccines: increased risk of adverse vaccine reactions.

Moderate Interactions (Monitor Closely): - Anticoagulants: potential alteration of coagulation parameters. - Hepatotoxic drugs: monitor liver function tests. - Other immunostimulants: risk of overstimulation of immune response.